TY - JOUR AU - Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer AU - Guida, Florence AU - Sun, Nan AU - Bantis, Leonidas E AU - Muller, David C AU - Li, Peng AU - Taguchi, Ayumu AU - Dhillon, Dilsher AU - Kundnani, Deepali L AU - Patel, Nikul J AU - Yan, Qingxiang AU - Byrnes, Graham AU - Moons, Karel G M AU - Tjønneland, Anne AU - Panico, Salvatore AU - Agnoli, Claudia AU - Vineis, Paolo AU - Palli, Domenico AU - Bueno-de-Mesquita, Bas AU - Peeters, Petra H AU - Agudo, Antonio AU - Huerta, Jose M AU - Dorronsoro, Miren AU - Barranco, Miguel Rodriguez AU - Ardanaz, Eva AU - Travis, Ruth C AU - Byrne, Karl Smith AU - Boeing, Heiner AU - Steffen, Annika AU - Kaaks, Rudolf AU - Hüsing, Anika AU - Trichopoulou, Antonia AU - Lagiou, Pagona AU - La Vecchia, Carlo AU - Severi, Gianluca AU - Boutron-Ruault, Marie-Christine AU - Sandanger, Torkjel M AU - Weiderpass, Elisabete AU - Nøst, Therese H AU - Tsilidis, Kostas AU - Riboli, Elio AU - Grankvist, Kjell AU - Johansson, Mikael AU - Goodman, Gary E AU - Feng, Ziding AU - Brennan, Paul AU - Johansson, Mattias AU - Hanash, Samir M PY - 2018 DO - 10.1001/jamaoncol.2018.2078 UR - http://hdl.handle.net/10668/12706 T2 - JAMA oncology AB - There is an urgent need to improve lung cancer risk assessment because current screening criteria miss a large proportion of cases. To investigate whether a lung cancer risk prediction model based on a panel of selected circulating protein biomarkers... LA - en KW - Aged KW - Aged, 80 and over KW - Biomarkers, Tumor KW - CA-125 Antigen KW - Carcinoembryonic Antigen KW - Female KW - Humans KW - Keratin-19 KW - Lung Neoplasms KW - Male KW - Mass Screening KW - Membrane Proteins KW - Middle Aged KW - Non-Smokers KW - Prospective Studies KW - Protein Precursors KW - Proteolipids KW - ROC Curve KW - Risk Assessment KW - Risk Factors KW - Tomography Scanners, X-Ray Computed TI - Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins. TY - research article VL - 4 ER -